129 related articles for article (PubMed ID: 10696354)
21. Stereotactic radiotherapy for nonsmall cell lung cancer.
Ball D
Curr Opin Pulm Med; 2008 Jul; 14(4):297-302. PubMed ID: 18520262
[TBL] [Abstract][Full Text] [Related]
22. [Effects of 5-FU (5-fluorouracil) in 4.3MeV Linac x-ray treatment of advanced cancer].
Tsuya A; Kaneda K; Okano S; Goto H
Gan No Rinsho; 1968 Apr; 14(4):340-52. PubMed ID: 4971113
[No Abstract] [Full Text] [Related]
23. [Relationship of bone marrow dose to eosinophilia following radiotherapy: a study of patients with breast, lung, cervical, and ovarian cancer].
Murohashi I; Gomi H; Nakano T; Morita S; Arai T; Jinnai I; Nara N; Bessho M; Hirashima K
Nihon Ketsueki Gakkai Zasshi; 1986 Nov; 49(7):1368-76. PubMed ID: 3825456
[No Abstract] [Full Text] [Related]
24. Escalated dose for non-small-cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapy.
Thirion P; Holmberg O; Collins CD; O'Shea C; Moriarty M; Pomeroy M; O'Sullivan C; Buckney S; Armstrong J
Radiother Oncol; 2004 May; 71(2):163-6. PubMed ID: 15110449
[TBL] [Abstract][Full Text] [Related]
25. The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands, 1995 to 2002.
Vulto AJ; Lemmens VE; Louwman MW; Janssen-Heijnen ML; Poortmans PH; Lybeert ML; Coebergh JW
Cancer; 2006 Jun; 106(12):2734-42. PubMed ID: 16703598
[TBL] [Abstract][Full Text] [Related]
26. Dosimetric comparison of four different external beam partial breast irradiation techniques: three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, helical tomotherapy, and proton beam therapy.
Moon SH; Shin KH; Kim TH; Yoon M; Park S; Lee DH; Kim JW; Kim DW; Park SY; Cho KH
Radiother Oncol; 2009 Jan; 90(1):66-73. PubMed ID: 18992950
[TBL] [Abstract][Full Text] [Related]
27. Combinations of radiation and misonidazole in a murine lung tumor model.
Siemann DW; Kochanski K
Radiat Res; 1981 May; 86(2):387-97. PubMed ID: 7232698
[No Abstract] [Full Text] [Related]
28. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
29. [The significance of the state of iodine metabolism in the development of general radiation reactions].
Palinkashi DG; Balybin ES
Med Radiol (Mosk); 1972 Sep; 17(9):37-40. PubMed ID: 4663979
[No Abstract] [Full Text] [Related]
30. [Dose-response relationship in radiotherapy: an evidence?].
Chauvet B; de Rauglaudre G; Mineur L; Alfonsi M; Reboul F
Cancer Radiother; 2003 Nov; 7 Suppl 1():8s-14s. PubMed ID: 15124539
[TBL] [Abstract][Full Text] [Related]
31. Radiobiological rationale and clinical implications of hypofractionated radiation therapy.
Ko EC; Forsythe K; Buckstein M; Kao J; Rosenstein BS
Cancer Radiother; 2011 Jun; 15(3):221-9. PubMed ID: 21514198
[TBL] [Abstract][Full Text] [Related]
32. [Radiotherapy for metastatic breast cancer].
Imajo Y
Nihon Rinsho; 2007 Jun; 65 Suppl 6():484-90. PubMed ID: 17682198
[No Abstract] [Full Text] [Related]
33. [Progress in radiotherapeutic approaches to anal, rectal, bronchial and prostatic cancers].
Van Houtte P; Mecellem H
Rev Med Brux; 1997 Sep; 18(4):213-7. PubMed ID: 9411645
[TBL] [Abstract][Full Text] [Related]
34. [New method of radiotherapy of lung neoplasms - radiotherapy with inhalation of 95% oxygen plus 5% carbon dioxide].
Oshima S; Sato A; Hamakawa J; Nadai M; Abe M
Bull Chest Dis Res Inst Kyoto Univ; 1975 Mar; 8(2):46-8. PubMed ID: 1164574
[No Abstract] [Full Text] [Related]
35. [Peripheral blood indices in preoperative radiotherapy (using radiomodifiers) of lung cancer].
Demidchik IuE; Zharkov VV; Prokhorova VI; Rubanova VZ
Med Radiol (Mosk); 1989 Sep; 34(9):49-52. PubMed ID: 2796643
[No Abstract] [Full Text] [Related]
36. [Combined and radiation therapy of rectal cancer using metronidazole].
Baran LA; el-Musa A; Ishchenko VE
Med Radiol (Mosk); 1984 Sep; 29(9):43-6. PubMed ID: 6482705
[No Abstract] [Full Text] [Related]
37. [Analysis of clinical experience in the use of metronidazole as a radiosensitizer of tumors].
Goldobenko GV; Kherkheulidze ZSh; Shchebetenko IuE; Polotskiĭ BE
Med Radiol (Mosk); 1983 Jul; 28(7):70-6. PubMed ID: 6348460
[No Abstract] [Full Text] [Related]
38. Radiation Therapy Intensification for Solid Tumors: A Systematic Review of Randomized Trials.
Yamoah K; Showalter TN; Ohri N
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):737-45. PubMed ID: 26530740
[TBL] [Abstract][Full Text] [Related]
39. [Present trends in the development of radiotherapy].
Kiseleva ES; Dar'ialova SL; Kvasov VA; Boĭko AV; Rakhmanin IuA; Poliakov PIu; Demidova LV; Zimina ES; Chernichenko AV; Ponomareva IV
Med Radiol (Mosk); 1991; 36(6):4-8. PubMed ID: 1861600
[TBL] [Abstract][Full Text] [Related]
40. Evidence-based clinicoradiobiological model for fractionation.
Sarin R
Lancet Oncol; 2006 Jun; 7(6):445-7. PubMed ID: 16750491
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
